Announcement of the Royal College of Chulabhorn He informed the media that there is a way to import an alternative vaccine “Sinopharm” (Sinopharm) to be used in the prevention and control of the epidemic of COVID-19 in Thailand. Together with the Ministry of Public Health And the Food and Drug Administration (FDA) on Friday, May 28, this has caused many parties to turn their attention to the Sino Farm alternative vaccine.
COVID-19 vaccine of Sino Farm Named BBIBP-CorV These are inactivated vaccines, which are vaccines produced from part or all of dead bacteria or viruses. Inactivated vaccines are widely used to provide immunity against infectious respiratory diseases such as influenza, including hepatitis, polio, and rabies. Because it is safe and effective in prevention
In addition, another advantage of the inactivated vaccine is: Easy to store and transport Can be stored in the temperature 2-8 degrees Celsius for many years. It is suitable for low income developing countries or places where there is a limit on cold storage equipment.
Foreign news agencies reported. BBIBP-CorV vaccine of Sino Farm Which requires 2 doses, it has been approved in 42 countries and territories around the world. It is the fourth most used after the AstraZeneca vaccine (166 countries), Pfizer-Biontec (94) and Moderna (46).
Recently, JAMA (The Journal of the American Medical Association), a world-recognized association of medical journals, has published its website. https://jamanetwork.com/ whenYesterday (May 26) on the results of a study of inactivated COVID vaccines, which are produced from two strains of the novel coronavirus, WIV04 and HB02, two of which were used primarily. In vaccine production BBIBP-CorV Of Sinopharm, the World Health Organization (WHO) has officially approved the use of the vaccine in an emergency since early May (7 May).
Data published by JAMA indicated that data was processed and analyzed from multiple Phase III (Phase 3) clinical trials (multicenter RCT), with a total of 40,382 adult subjects (ages 18 and older) from Bahrain. Egypt, UAE, Jordan, etc., compared to the use of a placebo (Alum only) .Vaccinated subjects were given two doses of the vaccine, spaced 21 days apart.
The results of the study showed that The efficacy of the prevention of COVID (symptomatic infection) was 72.8% and 78.1% for vaccines produced from WIV04 and HB02, respectively. It also had 100% prevention of both serious illness and the efficacy of infection prevention. (Both with and without symptoms) were 64% and 73.5%, respectively.
This is an effective vaccine to prevent COVID-related illness in the adult population.
Waiting for registration in Thailand
Dr. Paisan Dankhum, Secretary-General of the Food and Drug Administration or FDA, revealed on May 24 the progress of the approval of the COVID-19 vaccine. In Thailand that The Food and Drug Administration (FDA) has approved four cases of the COVID-19 vaccine:
- AstraZeneca vaccine by Astra Seneca (Thailand) Co., Ltd. and locally produced by Siam BioScience Co., Ltd.
- Sinovac’s CoronaVac vaccine imported by the Government Pharmaceutical Organization
- Johnson & Johnson Vaccine by Janssen-Zealac Company Limited
- Moderna vaccine by Zillic Pharma Co., Ltd.
Sino Farm’s Vaccine Division Which is submitted by Bio Genie Tech Co., Ltd. has submitted complete documents to The FDA is in the process of evaluating the registration request.
In addition, two other cases are currently in the process of submitting documents with ongoing registration requests, namely Covine Vaccine by Biogen Tech Co., Ltd. and Sputnik V by Kingen Biotech. Ltd.
The COVID-19 vaccine All items submitted for the FDA registration will consider both quality, safety and effectiveness, with the FDA ready to consider and approve the vaccine for Thai people to have the vaccine to be used asap.